PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
89 hedge funds and large institutions have $364M invested in Aratana Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8% less capital invested
Capital invested by funds: $396M → $364M (-$31.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $48K
Holders
89
Holding in Top 10
1
Calls
–
Puts
$48K
Top Buyers
| 1 | +$16.4M | |
| 2 | +$13.4M | |
| 3 | +$8.26M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.88M |
| 5 |
AP
Alydar Partners
Boston,
Massachusetts
|
+$2.81M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$6.26M | |
| 3 | -$4.86M | |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$4.25M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.14M |